iRhythm Technologies IRTC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
iRhythm Technologies (IRTC) Business Model and Operations Summary
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Key Insights
iRhythm Technologies (IRTC) Core Market Data and Business Metrics
Latest Closing Price
$106.88Market Cap
$3.36 BillionPrice-Earnings Ratio
-29.44Total Outstanding Shares
31.41 Million SharesTotal Employees
2,000Dividend
No dividendIPO Date
October 20, 2016SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
699 8th Street, San Francisco, CA, 94103
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $511.38 Million |
| Net Cash Flow From Operating Activities, Continuing | $3.39 Million |
| Net Cash Flow From Operating Activities | $3.39 Million |
| Net Cash Flow | $391.79 Million |
| Net Cash Flow, Continuing | $391.79 Million |
| Net Cash Flow From Financing Activities, Continuing | $511.38 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Revenues | $591.84 Million |
| Operating Expenses | $523.04 Million |
| Gross Profit | $407.53 Million |
| Operating Income/Loss | $-115.50 Million |
| Nonoperating Income/Loss | $2.78 Million |
| Basic Average Shares | $31.20 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-113.01 Million |
| Other Comprehensive Income/Loss | $277,000 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $-113.01 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $931.45 Million |
| Cash | $317.18 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Other Non-current Assets | $160.54 Million |
| Equity | $90.91 Million |
| Other Current Assets | $314.60 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||